The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.
Academia, government, and industry come together to address today’s most pressing issues in the regulation of medical products, from diversity in clinical trials to misinformation.
This year’s Seed Awards will support projects ranging from the discovery sciences and patient care to sustainability and diversity, equity, and inclusion
A large trial of a new drug regimen for tuberculosis, designed in part by School researchers, leads to a new WHO recommendation for treating the disease.
The UCSF School of Pharmacy is moving quickly against the COVID-19 pandemic, applying a scientific mindset to challenges being raised during the crisis.